Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
Open Access
- 3 October 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (10)
Abstract
Background: Higher concentrations of the apolipoprotein B (apoB) lipoproteins increase the risk of cardiovascular disease. However, whether the risk associated with apoB lipoproteins varies with age has not been well examined. Methods and Results: We determined the associations for total cholesterol, low‐density lipoprotein ( LDL )‐cholesterol ( LDL ‐C), non‐high‐density lipoprotein‐cholesterol (non‐ HDL ‐C), apoB, apolipoprotein A‐I (apoA‐I), and HDL ‐cholesterol ( HDL ‐C) with myocardial infarction at different ages in 11 760 controls and 8998 myocardial infarction cases of the INTERHEART Study. Logistic regression was used to compute the odds ratio of myocardial infarction for 1 SD change in each lipid marker by decade from 70 years of age. Except for those >70, plasma levels of total cholesterol, LDL ‐C, and non‐ HDL ‐C and apoB were greater in cases than controls. However, the average levels of these markers decreased significantly as age increased. By contrast, levels of apoA‐I and HDL ‐C were significantly greater in controls than cases but increased significantly as age increased. The cardiovascular risk associated with the atherogenic lipid markers differed at different ages. Most notably, there was a significant decline in the odds ratio for total cholesterol, LDL ‐C, and non‐ HDL ‐C, and apoB with increases in age whereas the odds ratios associated with apoA‐I and HDL ‐C were consistent across the age groups. Conclusions: These data indicate that the risk of cardiovascular events associated with apoB particles is greater in younger compared to older individuals. This finding is consistent with greater relative benefit from LDL ‐lowering therapy in younger compared to older individuals and so argues for therapy in younger individuals with elevated lipids.Keywords
This publication has 33 references indexed in Scilit:
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart DiseaseJACC, 2012
- Clinical implications of discordance between low-density lipoprotein cholesterol and particle numberJournal of Clinical Lipidology, 2011
- Familial-combined hyperlipidaemia in very young myocardial infarction survivors (<=40 years of age)European Heart Journal, 2009
- LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—Implications for LDL managementJournal of Clinical Lipidology, 2007
- Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and DeathNew England Journal of Medicine, 2006
- Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery diseaseJournal of Internal Medicine, 2006
- Sequence Variations inPCSK9,Low LDL, and Protection against Coronary Heart DiseaseNew England Journal of Medicine, 2006
- Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old ageEuropean Heart Journal, 2002
- A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of lifeEuropean Heart Journal, 1990